Related topics

Dicerna Pharmaceuticals: 2Q Earnings Snapshot

August 8, 2018

CAMBRIDGE, Mass. (AP) _ Dicerna Pharmaceuticals Inc. (DRNA) on Wednesday reported a loss of $35.6 million in its second quarter.

On a per-share basis, the Cambridge, Massachusetts-based company said it had a loss of 68 cents. Losses, adjusted for non-recurring costs, came to 28 cents per share.

The results topped Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 42 cents per share.

The biopharmaceutical company posted revenue of $1.5 million in the period, which did not meet Street forecasts. Three analysts surveyed by Zacks expected $1.8 million.

Dicerna Pharmaceuticals shares have climbed 59 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $14.32, more than quadrupling in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on DRNA at https://www.zacks.com/ap/DRNA

All contents © copyright 2019 The Associated Press.All rights reserved.